Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy☆
Background/Aims
Liver pathology induced by chemotherapy (steatosis or vascular injury) is known to increase the liver’s sensitivity to ischemia/ reperfusion (I/R) injury, thereby increasing morbidity and mortality after liver resection. Our aim was to assess whether ischemic preconditioning (IP) reduces I/R injury to livers with chemotherapy-induced pathology.
Methods
We analyzed a series of livers from patients treated with chemotherapy for colorectal cancer who underwent IP (n
=
30) or not (n
=
31) before hepatectomy. All but one of the livers exhibited chemotherapy-induced steatosis and/ or peliosis before the I/R insult.
Results
Necrosis was less frequent (p
=
0.038) in livers with IP than in the others. IP had no influence on apoptosis as assessed by terminal transferase uridyl nick-end labeling (TUNEL) assay or caspase-3, -8 and -9 expression. IP induced a twofold increase in B-cell leukemia/ lymphoma 2 (Bcl-2; p
<
0.05), which was localized to hepatocytes of centrolobular and peliotic areas and colocalized with the autophagy protein beclin-1 in livers with IP, suggesting their coordinated role in autophagy. Increased expression of the phosphorylated Bcl-2 was observed in preconditioned livers and was associated with a decreased immunoprecipitation of beclin-1 and the increased expression of light chain 3 type II (LC3-II). The increased number of autophagic vacuoles seen by electron microscopy confirmed an association of autophagy in chemotherapy-injured livers following IP. However, the differences in protein expression were not reflected in postresection liver-injury tests or measure of patient morbidity.
Conclusions
IP is associated with a reduction in necrosis of hepatocytes already damaged by chemotherapy and an activation of autophagy. Bcl-2 and beclin-1 could be major targets in the regulation of cell death during I/R injury.
Keywords: Cell death, Ischemia/reperfusion, Ischemic preconditioning, Chemotherapy, Bcl-2, Beclin-1, Autophagy, Liver
Abbreviations: ATP, adenosine triphosphate, BCIP/NBT, 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium, Bcl-2, B-cell leukemia/lymphoma 2, IP, ischemic preconditioning, I/R, ischemia/reperfusion, LC3-II, light chain 3 type II, SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, TUNEL, terminal transferase uridyl nick-end labeling
To access this article, please choose from the options below
☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.
PII: S0168-8278(09)00519-4
doi:10.1016/j.jhep.2009.06.028
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
